News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
TOFIDENCE™, a Biosimilar of ROACTEMRA® (Tocilizumab), Receives Approval in the European Union
Tuesday, June 25, 2024Biogen Inc has received approval from the European Commission for TOFIDENCE a biosimilar monoclonal antibody referencing ROACTEMRA This intravenous formulation
FDA Grants IND Approval for First Gene Therapy Targeting Common Neurological Conditions – EG 427 Commences Initial Human Clinical Trial
Monday, June 24, 2024EG a leading biotechnology company has received FDA clearance for clinical trials of EGA a gene therapy targeting Neurogenic Bladder NDO in spinal cord injury SCI patients This therapy utilizes
AriBio Co., Ltd. and Kentucky Clinical Trial Laboratory (KCTL) Collaborate to Expand Alzheimer’s Disease Testing
Saturday, June 22, 2024AriBio Co Ltd has announced a strategic collaboration with Kentucky Clinical Trial Laboratory to expand Alzheimers disease testing This partnership focuses on utilizing the Lumipulse system from FujireBio
FDA Approves Expansion of Gene Therapy for Duchenne Muscular Dystrophy
Friday, June 21, 2024The US Food and Drug Administration recently expanded its approval of Elevidys a gene therapy for Duchenne muscular dystrophy to include ambulatory and nonambulatory individuals aged years and older with a confirmed mutation in the DMD gene Initiall...
C-Path and CENTOGENE Enhance Collaboration in Advancing Lysosomal Disease Research and Drug Development
Friday, June 21, 2024The Critical Path Institute and Centogene NV have entered into a Memorandum of Understanding to collaborate on advancing drug development for lysosomal diseases and enhancing the quality
Abzena and Argonaut Collaborate to Enhance Support for Biopharmaceutical Drug Development
Friday, June 21, 2024Abzena a prominent contract development and manufacturing organization specializing in complex biologics and bioconjugates has formed a strategic partnership
Bit.bio Introduces ioAstrocytes, Enhancing Brain Modeling Capabilities for Researchers
Thursday, June 20, 2024Bitbio a pioneering company in synthetic biology focused on coding human cells for novel therapies has unveiled ioAstrocytes as its latest addition to the ioCells portfolio This new offering aims to revolutionize
Singleron Biotechnologies Collaborates with Human Cell Atlas to Broaden Global Access to Single-Cell Analysis
Wednesday, June 19, 2024Singleron Biotechnologies has partnered with the Human Cell Atlas to accelerate global adoption of singlecell sequencing Through this collaboration Singleron will provide its singlecell analysis platform
Ascidian Therapeutics Collaborates with Roche on RNA Exon Editing Treatments for Neurological Disorders
Wednesday, June 19, 2024Ascidian Therapeutics a company that specializes in RNAbased therapies has entered into a research collaboration and licensing agreement with Roche This collaboration aims to develop RNA exon
Neurona Therapeutics Obtains FDA RMAT Designation for NRTX-1001 in Treating Focal Epilepsy
Wednesday, June 19, 2024Neurona Therapeutics a company in the clinical stage focusing on regenerative cell therapies for disorders of the nervous system has received RMAT designation from the FDA
